Earnings Call · Q2 FY2022·2022-08-11

Q2 22EPS -100.00%*·Rev n/aQ1 22EPS 0.00%·Rev n/aQ4 21EPS -14.29%·Rev n/aQ3 21EPS +37.50%·Rev n/a⚠ consensus missing

ZEVRA THERAPEUTICS, INC. ZVRA

Nichol Ochsner — Investor Relations or Communications

Travis Mickle — CEO

Perry Sternberg — Executive (likely CEO or Commercial Head)

LaDuane Clifton — CFO

−1.1%1d on move date−2.8% vs SPY3d−10.7%5d−9.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ZVRA calls or request research access.

More ZVRA calls Browse calls Request research access